Tectonic Therapeutic, Inc.

TECXNASDAQHealthcareBiotechnology

$19.95- (-)1Y +21.28%

As of Oct 26, 2026 close

Market cap: $378.33M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $15.52$39.53
Volume (live): -
Avg. volume (3M): 228.72K

Tectonic Therapeutic, Inc. (TECX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Tectonic Therapeutic, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

(10 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$69.75

+249.62% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest TECX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 16, 2026	David Risinger	Leerink Partners	Reiterates	Buy	$60.00
Oct 14, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$76.00
Oct 11, 2026	Alice Nettleton	UBS	Initiates	Hold	$26.00
Oct 1, 2026	James Condulis	Stifel Nicolaus	Maintains	Buy	$75.00
Sep 30, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$76.00
Sep 30, 2026	Benjamin Burnett	Wells Fargo	Reiterates	Buy	$93.00
Sep 29, 2026	Gaurav Maini	LifeSci Capital	Maintains	Buy	$88.00
Sep 29, 2026	Benjamin Burnett	Wells Fargo	Initiates Coverage	Buy	$93.00
Sep 1, 2026	Unknown Analyst	Oppenheimer	Reiterates	Buy	$80.00
Aug 10, 2026	Danielle Brill	Truist	Maintains	Buy	$60.00

David Risinger

Leerink Partners

BuyReiterates

$60.00

Oct 16

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$76.00

Oct 14

Alice Nettleton

UBS

HoldInitiates

$26.00

Oct 11

James Condulis

Stifel Nicolaus

BuyMaintains

$75.00

Oct 1

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$76.00

Sep 30

Benjamin Burnett

Wells Fargo

BuyReiterates

$93.00

Sep 30

Gaurav Maini

LifeSci Capital

BuyMaintains

$88.00

Sep 29

Benjamin Burnett

Wells Fargo

BuyInitiates Coverage

$93.00

Sep 29

Unknown Analyst

Oppenheimer

BuyReiterates

$80.00

Sep 1

Danielle Brill

Truist

BuyMaintains

$60.00

Aug 10

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for TECX?

The analyst consensus rating for TECX is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for TECX?

The average 12-month price target for TECX is $69.75, representing an upside of 249.6% from the Oct 26, 2026 close of $19.95.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.